Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Peter Lin MD, CCFP
Peter Lin MD, CCFP Associate Editor
See All Experts
featured
Published in Primary Care

Journal Scan / Research · November 13, 2024

Comparative Effectiveness of SGLT2 Inhibitors for Recurrent Nephrolithiasis

BMJ: British Medical Journal

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Timothy Overton MD, MPH

BMJ: British Medical Journal
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies
BMJ 2024 Oct 30;387(xx)e080035, N McCormick, C Yokose, N Lu, DJ Wexler, JA Aviña-Zubieta, MA De Vera, S Chigurupati, K Tan, C Chen, R McCoy, GC Curhan, HK Choi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated